Sort
39,280 grants matching “leukemia”
Targeted Therapy for Leukemia
$914,298John C Byrd · Ohio State University · R35 · FY2020 · CA
Hematopathology Diagnosis
$914,053Elaine Jaffe · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Translational Development of Replication-Competent Retrovirus Vectors
$913,956Noriyuki Kasahara · University Of California Los Angeles · U01 · FY2011 · NS
Microfluidic CAR-T Cell Processing Device
$913,556Tony Ward · Gpb Scientific, Inc. · R42 · FY2020 · CA
Molecular strategies for early detection and targeting of cancer
$913,500Tannishtha Reya · University Of California, San Diego · R35 · FY2015 · CA
PLCO Trial Etiologic and Early Marker Study
$912,943Richard S Hayes · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
MOLECULAR TAXONOMY OF PEDIATRIC AND ADULT ACUTE LEUKEMIA
$912,789University Of New Mexico · U01 · FY2001 · CA
Therapeutic Targeting of Human AML Stem Cells
$912,708Craig T. Jordan · University Of Colorado Denver · R35 · FY2022 · CA
NHGRI/DIR Genomics Core
$912,066Settara Chandrasekharappa · National Human Genome Research Institute · ZIC · FY2016 · HG
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2021 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2020 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2015 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2017 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2016 · CA
Research and Development of Effective Therapies for Patients with Rare Tumors
$911,495Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
Targeted Therapy for Leukemia
$911,328John C Byrd · Ohio State University · R35 · FY2015 · CA
Precision quality check of immunotherapeutics via single-cell cytokine mapping
$910,459Jing Zhou · Isoplexis, Inc. · R44 · FY2018 · CA
Targeted Therapy for Leukemia
$910,045John C Byrd · Ohio State University · R35 · FY2017 · CA
Diazeniumdiolates as Broad-Spectrum Anticancer Agents
$909,984Larry K Keefer · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Human Monoclonal Antibodies Against Cancer
$909,717Dimiter S Dimitrov · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Molecular strategies for early detection and targeting of cancer
$909,506Tannishtha Reya · University Of California, San Diego · R35 · FY2017 · CA
NMR Research Core Facility
$909,415Geoffrey Mueller · National Institute Of Environmental Health Sciences · ZIC · FY2024 · ES
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence
$908,973Joshua Tisdell Schiffer · Fred Hutchinson Cancer Center · R56 · FY2023 · AI
Computational Tools For Bioinformatics And Genome Analysis
$908,951John I Powell · Center For Information Technology · ZIA · FY2012 · CT
Mechanisms of non-classical multidrug resistance in cancer
$908,705Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA